| 215 | 0 | 50 |
| 下载次数 | 被引频次 | 阅读次数 |
早发性卵巢功能不全(POI)是女性40岁之前出现的卵巢功能衰退或丧失，严重影响女性身心健康和生育功能，目前临床尚无法提供治愈方法。间充质干细胞(MSCs)来源广泛，具有再生、增殖及修复受损组织的本领，在POI治疗领域具有广阔应用前景。但MSCs的推广应用仍面临难题，如进入体内后存活率低、旁分泌及分化能力受损、活细胞包装及运输的局限性、临床应用存在致瘤或诱发免疫反应等。因此，探索不同形式的MSCs优化策略以解决上述难题成为当前研究热点。本文总结了当前MSCs治疗POI的研究进展，综述了近年来MSCs治疗POI的优化策略，以期进一步为POI的治疗提供参考依据。
Abstract：Primary Ovarian Insufficiency(POI) is the decline or loss of ovarian function that occurs before the age of 40,which seriously affects woman's physical and mental health as well as their reproductive function. And clinically, there is no known cure. Mesenchymal stem cells(MSCs),which come from a wide range of sources and have the ability to regenerate, proliferate and repair damaged tissues, have a broad prospect in POI treatment. However, the application of MSCs still faces difficulties, such as low survival rate in vivo, impaired paracrine and differentiation abilities, limitations in packaging and transportation of living cells, and tumorigenic or immune-induced reactions in clinical applications. Therefore, it has become a hot research topic to explore strategies for the optimization of MSCs treatments. In this paper, we summarize the current research progress of MSCs for POI,and review the optimization strategies for MSCs-based treatment of POI in recent years, with a view to further providing a reference basis for the treatment of POI.
[1] Chon SJ,Umair Z,Yoon MS.Premature ovarian insufficiency:past,present,and future[J].Front Cell Dev Biol,2021,9:672890.
[2] Ishizuka B.Current understanding of the etiology,symptomatology,and treatment options in premature ovarian insufficiency(POI)[J].Front Endocrinol(Lausanne),2021,12:626924.
[3] Liu J,Gao J,Liang Z,et al.Mesenchymal stem cells and their microenvironment[J].Stem Cell Res Ther,2022,13:429.
[4] Wang J,Liu W,Yu D,et al.Research progress on the treatment of premature ovarian failure using mesenchymal stem cells:a literature review[J].Front Cell Dev Biol,2021,9:749822.
[5] Cui L,Bao H,Liu Z,et al.hUMSCs regulate the differentiation of ovarian stromal cells via TGF-β(1)/Smad3 signaling pathway to inhibit ovarian fibrosis to repair ovarian function in POI rats[J].Stem Cell Res Ther,2020,11:386.
[6] Park HS,Chugh RM,Elsharoud A,et al.Safety of intraovarian injection of human mesenchymal stem cells in a premature ovarian insufficiency mouse model[J].Cell Transplant,2021,30:963689720988502.
[7] 姚瑶，张丽娜，纪亚忠.早发性卵巢功能不全的干细胞治疗进展[J].生殖医学杂志，2022,31:1309-1313.
[8] He Y,Chen D,Yang L,et al.The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure[J].Stem Cell Res Ther,2018,9:263.
[9] Wang Z,Wang Y,Yang T,et al.Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice[J].Stem Cell Res Ther,2017,8:11.
[10] 叶红娟，石丽雅，全心馨，等.不同间充质干细胞及外泌体治疗宫腔粘连的研究进展[J].生殖医学杂志，2023,32:793-797.
[11] Wang Q,Li X,Wang Q,et al.Heat shock pretreatment improves mesenchymal stem cell viability by heat shock proteins and autophagy to prevent cisplatin-induced granulosa cell apoptosis[J].Stem Cell Res Ther,2019,10:348.
[12] Ling L,Feng X,Wei T,et al.Effects of low-intensity pulsed ultrasound(LIPUS)-pretreated human amnion-derived mesenchymal stem cell(hAD-MSC) transplantation on primary ovarian insufficiency in rats[J].Stem Cell Res Ther,2017,8:283.
[13] Huang D,Gao Y,Wang S,et al.Impact of low-intensity pulsed ultrasound on transcription and metabolite compositions in proliferation and functionalization of human adipose-derived mesenchymal stromal cells[J].Sci Rep,2020,10:13690.
[14] 张莉，杨俊晔，房敬超，等.低氧培养环境对脐带间充质干细胞增殖及生物学特性的影响[J].药物评价研究，2022,45:886-894.
[15] 赵越，阮祥燕，王凤春，等.低氧预处理人脐带间充质干细胞治疗早发性卵巢功能不全小鼠的效果研究[J].首都医科大学学报，2019,40:566-571.
[16] Moeinabadi-Bidgoli K,Babajani A,Yazdanpanah G,et al.Translational insights into stem cell preconditioning:from molecular mechanisms to preclinical applications[J].Biomed Pharmacother,2021,142:112026.
[17] Sudres M,Maurer M,Robinet M,et al.Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model[J].JCI Insight,2017,2:e89665.
[18] Huang QY,Chen SR,Zhao YX,et al.Melatonin enhances autologous adipose-derived stem cells to improve mouse ovarian function in relation to the SIRT6/NF-κB pathway[J].Stem Cell Res Ther,2022,13:399.
[19] Wang J,Zhao Y,Zheng F,et al.Activated human umbilical cord blood platelet-rich plasma enhances the beneficial effects of human umbilical cord mesenchymal stem cells in chemotherapy-induced POF rats[J].Stem Cells Int,2021,2021:8293699.
[20] Zhang S,Zhu D,Mei X,et al.Advances in biomaterials and regenerative medicine for primary ovarian insufficiency therapy[J].Bioact Mater,2020,6:1957-1972.
[21] Yang Y,Lei L,Wang S,et al.Transplantation of umbilical cord-derived mesenchymal stem cells on a collagen scaffold improves ovarian function in a premature ovarian failure model of mice[J].In Vitro Cell Dev Biol Anim,2019,55:302-311.
[22] Ding L,Yan G,Wang B,et al.Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility[J].Sci China Life Sci,2018,61:1554-1565.
[23] Shin EY,Kim DS,Lee MJ,et al.Prevention of chemotherapy-induced premature ovarian insufficiency in mice by scaffold-based local delivery of human embryonic stem cell-derived mesenchymal progenitor cells[J].Stem Cell Res Ther,2021,12:431.
[24] Jiao W,Mi X,Yang Y,et al.Mesenchymal stem cells combined with autocrosslinked hyaluronic acid improve mouse ovarian function by activating the PI3K-AKT pathway in a paracrine manner[J].Stem Cell Res Ther,2022,13:49.
[25] Green LJ,Zhou H,Padmanabhan V,et al.Adipose-derived stem cells promote survival,growth,and maturation of early-stage murine follicles[J].Stem Cell Res Ther,2019,10:102.
[26] Pawitan JA.Prospect of stem cell conditioned medium in regenerative medicine[J].Biomed Res Int,2014,2014:965849.
[27] Ra K,Park SC,Lee BC.Female reproductive aging and oxidative stress:mesenchymal stem cell conditioned medium as a promising antioxidant[J].Int J Mol Sci,2023,24:5053.
[28] Gunawardena TNA,Rahman MT,Abdullah JJ,et al.Conditioned media derived from mesenchymal stem cell cultures:The next generation for regenerative medicine[J].J Tissue Eng Regen Med,2019,13:569-586.
[29] Hong L,Yan L,Xin Z,et al.Protective effects of human umbilical cord mesenchymal stem cell-derived conditioned medium on ovarian damage[J].J Mol Cell Biol,2020,12:372-385.
[30] Shin S,Lee J,Kwon Y,et al.Comparative proteomic analysis of the mesenchymal stem cells secretome from adipose,bone marrow,placenta and Wharton’s Jelly[J].Int J Mol Sci,2021,22:845.
[31] Ra K,Oh HJ,Kim EY,et al.Comparison of anti-oxidative effect of human adipose- and amniotic membrane-derived mesenchymal stem cell conditioned medium on mouse preimplantation embryo development[J].Antioxidants(Basel),2021,10:268.
[32] Yaghoubi Y,Movassaghpour A,Zamani M,et al.Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment[J].Life Sci,2019,233:116733.
[33] Karnas E,Dudek P,Zuba-Surma EK.Stem cell-derived extracellular vesicles as new tools in regenerative medicine-immunomodulatory role and future perspectives[J].Front Immunol,2023,14:1120175.
[34] Ding C,Qian C,Hou S,et al.Exosomal miRNA-320a is released from hAMSCs and regulates SIRT4 to prevent reactive oxygen species generation in POI[J].Mol Ther Nucleic Acids,2020,21:37-50.
[35] Park HS,Chugh RM,Seok J,et al.Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency:as promising as cells but different persistency and dosage[J].Stem Cell Res Ther,2023,14:165.
[36] Yang M,Lin L,Sha C,et al.Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN[J].Lab Invest,2020,100:342-352.
[37] Li Z,Zhang M,Zheng J,et al.Human umbilical cord mesenchymal stem cell-derived exosomes improve ovarian function and proliferation of premature ovarian insufficiency by regulating the Hippo signaling pathway[J].Front Endocrinol(Lausanne),2021,12:711902.
[38] Liu C,Yin H,Jiang H,et al.Extracellular vesicles derived from mesenchymal stem cells recover fertility of premature ovarian insufficiency mice and the effects on their offspring[J].Cell Transplant,2020,29:963689720923575.
[39] Yang Z,Du X,Wang C,et al.Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice[J].Stem Cell Res Ther,2019,10:250.
[40] Huang B,Lu J,Ding C,et al.Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD[J].Stem Cell Res Ther,2018,9:216.
[41] Thabet E,Yusuf A,Abdelmonsif DA,et al.Extracellular vesicles miRNA-21:a potential therapeutic tool in premature ovarian dysfunction[J].Mol Hum Reprod,2020,26:906-919.
[42] Chen S,Wang Y,Liao L,et al.Similar repair effects of human placenta,bone marrow mesenchymal stem cells,and their exosomes for damaged SVOG ovarian granulosa cells[J].Stem Cells Int,2020,2020:8861557.
[43] Zhang S,Huang B,Su P,et al.Concentrated exosomes from menstrual blood-derived stromal cells improves ovarian activity in a rat model of premature ovarian insufficiency[J].Stem Cell Res Ther,2021,12:178.
[44] Akhter W,Nakhle J,Vaillant L,et al.Transfer of mesenchymal stem cell mitochondria to CD4(+) T cells contributes to repress Th1 differentiation by downregulating T-bet expression[J].Stem Cell Res Ther,2023,14:12.
[45] Labarta E,de Los Santos MJ,Escribá MJ,et al.Mitochondria as a tool for oocyte rejuvenation[J].Fertil Steril,2019,111:219-226.
[46] Zhang C,Tao L,Yue Y,et al.Mitochondrial transfer from induced pluripotent stem cells rescues developmental potential of in vitro fertilized embryos from aging females[J].Biol Reprod,2021,104:1114-1125.
[47] Morimoto Y,Gamage USK,Yamochi T,et al.Mitochondrial transfer into human oocytes improved embryo quality and clinical outcomes in recurrent pregnancy failure cases[J].Int J Mol Sci,2023,24:2738.
[48] 刘紫君，常惠，王宇，等.干细胞治疗生殖系统疾病的研究进展[J].生殖医学杂志，2021,30:836-841.
基本信息:
中图分类号:R711.75
引用信息:
[1]范沛吟,张佳丽,徐键,等.基于间充质干细胞治疗早发性卵巢功能不全优化策略的研究进展[J].生殖医学杂志,2024,33(04):546-552.
2023-08-29
2023
2024-02-23
2024
2
2024-04-15
2024-04-15